Real-time enrollment status for this her2 positive cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT05523947 |
| Recruiting Status | Recruiting |
| Condition | HER2 Positive Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 137 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Yuhan Corporation |
| Last Updated on CT.gov | February 24, 2026 (6 days ago) |
As of March 2, 2026: Clinical trial NCT05523947 is currently recruiting participants. This clinical trial study for her2 positive cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Yuhan Corporation. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05523947 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05523947 was last updated 6 days ago (February 24, 2026). HelloStudys verifies this status automatically.